UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003900
Receipt number R000004692
Scientific Title Phase II trial of axilla treatment after primary chemotherapy for breast cancer patients with sentinel lymph node metastases
Date of disclosure of the study information 2010/07/14
Last modified on 2012/07/04 14:23:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase II trial of axilla treatment after primary chemotherapy for breast cancer patients with sentinel lymph node metastases

Acronym

Axilla treatment after chemotherapy for sentinel node-positive breast cancer patients

Scientific Title

Phase II trial of axilla treatment after primary chemotherapy for breast cancer patients with sentinel lymph node metastases

Scientific Title:Acronym

Axilla treatment after chemotherapy for sentinel node-positive breast cancer patients

Region

Japan


Condition

Condition

Breast cancer

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify axilla management after neoadjuvant chemotherapy for breast cancer patients with pN1mi(sn) or pN1(sn)

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Positive rate of axillary nodes after primary chemtoherapy

Key secondary outcomes

5-year overall survival rate of breast cancer patients after primary chemotherapy


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

Sentinel node biopsy, primary chemotherapy, breast surgery with axillary lymph node dissection

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >=

Gender

Female

Key inclusion criteria

T1-3N0M0
Invasive cancer
pN1mi(sn) or pN1(sn)

Key exclusion criteria

Breast cancer patient during pregnancy
Bilateral breast cancer
Primary endocrine therapy

Target sample size

98


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shigeru Imoto

Organization

School of Medicine, Kyorin University

Division name

Department of Breast Surgery

Zip code


Address

6-20-2 Shinkawa Mmitaka Tokyo 181-8611, JAPAN

TEL

0422-47-5511

Email



Public contact

Name of contact person

1st name
Middle name
Last name Satomi Yana

Organization

Japanese Society for Sentinel Node Navigation Surgery

Division name

Office

Zip code


Address

Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku,Tokyo

TEL

03-3353-6440

Homepage URL


Email

yanas@sc.itc.keio.ac.jp


Sponsor or person

Institute

Japanese Society for Sentinel Node Navigation Surgery

Institute

Department

Personal name



Funding Source

Organization

Japanese Society for Sentinel Node Navigation Surgery

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

旭川医科大学病院(北海道)、岩手医科大学病院(岩手)、山形県立中央病院(山形)、山形大学病院(山形)、福島県立医科大学病院(福島)、佐野厚生総合病院 (栃木)、埼玉社会保険病院(埼玉)、埼玉県立がんセンター(埼玉)、国立がん研究センター東病院(千葉)、千葉大学病院(千葉)、慶應義塾大学病院(東京)、国立がん研究センター中央病院(東京)、虎の門病院(東京)、日野市立病院(東京)、杏林大学病院(東京)、神奈川県立がんセンター(神奈川)、愛知医科大学 病院(愛知)、松波総合病院(岐阜)、国立病院機構大阪医療センター(大阪)、
関西医科大学附属枚方病院(大阪)、大阪市立大学病院(大阪)、長崎大学病院(長崎)、鹿児島大学病院(鹿児島)


Other administrative information

Date of disclosure of the study information

2010 Year 07 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2010 Year 04 Month 17 Day

Date of IRB


Anticipated trial start date

2010 Year 06 Month 01 Day

Last follow-up date

2016 Year 04 Month 01 Day

Date of closure to data entry


Date trial data considered complete

2016 Year 08 Month 01 Day

Date analysis concluded

2016 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2010 Year 07 Month 10 Day

Last modified on

2012 Year 07 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004692


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name